August 3, 2026 · European heart journal · DOI: 10.1093/eurheartj/ehag578

Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction

Listen to this summary

The authors investigate the role of mineralocorticoid receptor (MR) overactivation in the development and progression of heart failure with preserved ejection fraction (HFpEF), exploring its mechanistic pathways and potential therapeutic interventions. They highlight how MR overactivation contributes to key features of HFpEF and suggest that targeting this pathway with MR antagonists or inhibitors could improve patient outcomes. The paper calls for a reevaluation of treatment strategies in clinical practice to address MR overactivation in HFpEF.

Masatake Kobayashi, Bertram Pitt, Faiez Zannad

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play